Bain Capital co-chair: 'Private equity gets a bad rap' politically — we don't destroy jobs [CNBC]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: CNBC
Steve Pagliuca, co-chair of private equity powerhouse Bain Capital, defended the industry, arguing Thursday that it has received an undeserved bad reputation. Private equity has actually been a "great thing for America," he said on CNBC's "Squawk Box" "No one wants to buy a company that is shrinking, so we spend all of our time thinking, 'How do we grow companies? How do we do more R&D? How do we invest in new products?'" he explained. faced criticism recently from Democratic presidential candidates Elizabeth Warren Bernie Sanders The 2020 primary is not the first time private equity has drawn the ire of politicians. In the 2012 presidential election, then-GOP nominee and former Massachusetts Gov. Mitt Romney criticized for his past work at Bain Capital, Opponents of private equity take aim at the way those firms acquire companies and load them with debt. Critics argue that private equity firms enrich themselves through dividends and other means — such as a standard 2% annual fee and
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Everest Medicines Announces Financial Results for Full Year Ended December 31, 2023 [Yahoo! Finance]Yahoo! Finance
- Global Metastatic Melanoma Therapeutics Market Anticipates Robust Growth with New Therapeutic Developments [Yahoo! Finance]Yahoo! Finance
- CStone Pharmaceuticals Reports 2023 Annual Results and Business Updates [Yahoo! Finance]Yahoo! Finance
- Is Most-Watched Stock Pfizer Inc. (PFE) Worth Betting on Now? [Yahoo! Finance]Yahoo! Finance
- US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030: A $1.28 Trillion Opportunity, Driven by the Rising Adoption of AI-based Tools for Drug Discovery [Yahoo! Finance]Yahoo! Finance
PFE
Earnings
- 1/30/24 - Beat
PFE
Sec Filings
- 3/18/24 - Form 4
- 3/18/24 - Form 4
- 3/14/24 - Form ARS
- PFE's page on the SEC website